Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fmicb.2025.1603671
Immunotoxins (ITs), as targeted cancer therapies, confront limitations including off-target effects, immunogenicity, and inadequate tumor penetration, hindering clinical translation. Advances in tumor microenvironment (TME) understanding and genetic engineering have enabled engineered microorganisms such as attenuated Salmonella , E. coli Nissle 1917, and modified eukaryotic platforms (e.g., yeast, microalgae) to colonize tumors and act as efficient hosts for IT production. By integrating ITs into these microbes and employing precise circuits (e.g., phage lysis systems, signal peptide fusions), controlled secretion of recombinant immunotoxins (RITs) can be achieved. Balanced-lethal systems further enhance plasmid stability for sustained therapeutic delivery. This review highlights strategies leveraging engineered microbes to amplify IT efficacy, exemplified by preclinical successes like Salmonella -delivered TGFα-PE38 and E. coli -expressed anti-PD-L1-PE38. However, challenges persist, including dynamic TME interactions, systemic infection risks, manufacturing complexities and regulatory uncertainties demand resolution. By synergizing microbial targeting with RIT, this approach offers transformative potential for cancer therapy, yet requires multidisciplinary innovation to address technical, safety, and regulatory barriers for clinical adoption.
Related Topics
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.3389/fmicb.2025.1603671
- https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1603671/pdf
- OA Status
- gold
- References
- 77
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411064900
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411064900Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fmicb.2025.1603671Digital Object Identifier
- Title
-
Unlocking the potential of engineered microbes in immunotoxin-based cancer therapyWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-05Full publication date if available
- Authors
-
Quan Wang, Rui Cao, Yuan Xie, Zhuoyi Zhang, Xianguo Li, Yan Zhang, Haolin Luo, Hui Yao, Ping Xue, Shuai NiList of authors in order
- Landing page
-
https://doi.org/10.3389/fmicb.2025.1603671Publisher landing page
- PDF URL
-
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1603671/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1603671/pdfDirect OA link when available
- Concepts
-
Immunotoxin, Biomanufacturing, Immunogenicity, Tumor microenvironment, Computational biology, Cancer research, Biology, Immune system, Biotechnology, Immunology, Tumor cells, Antibody, Monoclonal antibodyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
77Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411064900 |
|---|---|
| doi | https://doi.org/10.3389/fmicb.2025.1603671 |
| ids.doi | https://doi.org/10.3389/fmicb.2025.1603671 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40539104 |
| ids.openalex | https://openalex.org/W4411064900 |
| fwci | 0.0 |
| type | review |
| title | Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy |
| biblio.issue | |
| biblio.volume | 16 |
| biblio.last_page | 1603671 |
| biblio.first_page | 1603671 |
| topics[0].id | https://openalex.org/T12996 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1305 |
| topics[0].subfield.display_name | Biotechnology |
| topics[0].display_name | Cancer Research and Treatments |
| topics[1].id | https://openalex.org/T11048 |
| topics[1].field.id | https://openalex.org/fields/23 |
| topics[1].field.display_name | Environmental Science |
| topics[1].score | 0.9776999950408936 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2303 |
| topics[1].subfield.display_name | Ecology |
| topics[1].display_name | Bacteriophages and microbial interactions |
| topics[2].id | https://openalex.org/T10878 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9728000164031982 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | CRISPR and Genetic Engineering |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| concepts[0].id | https://openalex.org/C115085202 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7981950640678406 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q425665 |
| concepts[0].display_name | Immunotoxin |
| concepts[1].id | https://openalex.org/C2775893736 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7419227957725525 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q25324110 |
| concepts[1].display_name | Biomanufacturing |
| concepts[2].id | https://openalex.org/C2780868878 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5028893351554871 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1660197 |
| concepts[2].display_name | Immunogenicity |
| concepts[3].id | https://openalex.org/C2776107976 |
| concepts[3].level | 3 |
| concepts[3].score | 0.4862064719200134 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1786433 |
| concepts[3].display_name | Tumor microenvironment |
| concepts[4].id | https://openalex.org/C70721500 |
| concepts[4].level | 1 |
| concepts[4].score | 0.433609277009964 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[4].display_name | Computational biology |
| concepts[5].id | https://openalex.org/C502942594 |
| concepts[5].level | 1 |
| concepts[5].score | 0.43061119318008423 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[5].display_name | Cancer research |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.3678961396217346 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C8891405 |
| concepts[7].level | 2 |
| concepts[7].score | 0.3534114360809326 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[7].display_name | Immune system |
| concepts[8].id | https://openalex.org/C150903083 |
| concepts[8].level | 1 |
| concepts[8].score | 0.27796366810798645 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7108 |
| concepts[8].display_name | Biotechnology |
| concepts[9].id | https://openalex.org/C203014093 |
| concepts[9].level | 1 |
| concepts[9].score | 0.21270084381103516 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[9].display_name | Immunology |
| concepts[10].id | https://openalex.org/C3020616263 |
| concepts[10].level | 2 |
| concepts[10].score | 0.17269182205200195 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1216998 |
| concepts[10].display_name | Tumor cells |
| concepts[11].id | https://openalex.org/C159654299 |
| concepts[11].level | 2 |
| concepts[11].score | 0.1148596704006195 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[11].display_name | Antibody |
| concepts[12].id | https://openalex.org/C542903549 |
| concepts[12].level | 3 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q422248 |
| concepts[12].display_name | Monoclonal antibody |
| keywords[0].id | https://openalex.org/keywords/immunotoxin |
| keywords[0].score | 0.7981950640678406 |
| keywords[0].display_name | Immunotoxin |
| keywords[1].id | https://openalex.org/keywords/biomanufacturing |
| keywords[1].score | 0.7419227957725525 |
| keywords[1].display_name | Biomanufacturing |
| keywords[2].id | https://openalex.org/keywords/immunogenicity |
| keywords[2].score | 0.5028893351554871 |
| keywords[2].display_name | Immunogenicity |
| keywords[3].id | https://openalex.org/keywords/tumor-microenvironment |
| keywords[3].score | 0.4862064719200134 |
| keywords[3].display_name | Tumor microenvironment |
| keywords[4].id | https://openalex.org/keywords/computational-biology |
| keywords[4].score | 0.433609277009964 |
| keywords[4].display_name | Computational biology |
| keywords[5].id | https://openalex.org/keywords/cancer-research |
| keywords[5].score | 0.43061119318008423 |
| keywords[5].display_name | Cancer research |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.3678961396217346 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/immune-system |
| keywords[7].score | 0.3534114360809326 |
| keywords[7].display_name | Immune system |
| keywords[8].id | https://openalex.org/keywords/biotechnology |
| keywords[8].score | 0.27796366810798645 |
| keywords[8].display_name | Biotechnology |
| keywords[9].id | https://openalex.org/keywords/immunology |
| keywords[9].score | 0.21270084381103516 |
| keywords[9].display_name | Immunology |
| keywords[10].id | https://openalex.org/keywords/tumor-cells |
| keywords[10].score | 0.17269182205200195 |
| keywords[10].display_name | Tumor cells |
| keywords[11].id | https://openalex.org/keywords/antibody |
| keywords[11].score | 0.1148596704006195 |
| keywords[11].display_name | Antibody |
| language | en |
| locations[0].id | doi:10.3389/fmicb.2025.1603671 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2484704948 |
| locations[0].source.issn | 1664-302X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1664-302X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Microbiology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1603671/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Microbiology |
| locations[0].landing_page_url | https://doi.org/10.3389/fmicb.2025.1603671 |
| locations[1].id | pmid:40539104 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in microbiology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40539104 |
| locations[2].id | pmh:oai:doaj.org/article:134cfc323aed4423b8ed2bfcfc86debb |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Frontiers in Microbiology, Vol 16 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/134cfc323aed4423b8ed2bfcfc86debb |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:12177715 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Front Microbiol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12177715 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5100418282 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4997-7173 |
| authorships[0].author.display_name | Quan Wang |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I180726961 |
| authorships[0].affiliations[0].raw_affiliation_string | Guangdong Provincial Key Laboratory for Plant Epigenetics, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210101555 |
| authorships[0].affiliations[1].raw_affiliation_string | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[0].institutions[0].id | https://openalex.org/I4210101555 |
| authorships[0].institutions[0].ror | https://ror.org/018wg9441 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210101555 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Hubei University of Science and Technology |
| authorships[0].institutions[1].id | https://openalex.org/I180726961 |
| authorships[0].institutions[1].ror | https://ror.org/01vy4gh70 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I180726961 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | Shenzhen University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Quan Wang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Guangdong Provincial Key Laboratory for Plant Epigenetics, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China., School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[1].author.id | https://openalex.org/A5100659762 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7365-7615 |
| authorships[1].author.display_name | Rui Cao |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Anesthesiology, People's Hospital of Xinzhou, Wuhan, China. |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Rui Cao |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Anesthesiology, People's Hospital of Xinzhou, Wuhan, China. |
| authorships[2].author.id | https://openalex.org/A5011053643 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5356-6660 |
| authorships[2].author.display_name | Yuan Xie |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210101555 |
| authorships[2].affiliations[0].raw_affiliation_string | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[2].institutions[0].id | https://openalex.org/I4210101555 |
| authorships[2].institutions[0].ror | https://ror.org/018wg9441 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210101555 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Hubei University of Science and Technology |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yuxing Xie |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[3].author.id | https://openalex.org/A5089302540 |
| authorships[3].author.orcid | https://orcid.org/0009-0001-0308-6861 |
| authorships[3].author.display_name | Zhuoyi Zhang |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210101555 |
| authorships[3].affiliations[0].raw_affiliation_string | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[3].institutions[0].id | https://openalex.org/I4210101555 |
| authorships[3].institutions[0].ror | https://ror.org/018wg9441 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210101555 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Hubei University of Science and Technology |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Zhuoyi Zhang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[4].author.id | https://openalex.org/A5101795783 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Xianguo Li |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210101555 |
| authorships[4].affiliations[0].raw_affiliation_string | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[4].institutions[0].id | https://openalex.org/I4210101555 |
| authorships[4].institutions[0].ror | https://ror.org/018wg9441 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210101555 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Hubei University of Science and Technology |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Xianguo Li |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[5].author.id | https://openalex.org/A5100456257 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-5022-362X |
| authorships[5].author.display_name | Yan Zhang |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210129556 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Anesthesiology, Yunxi People's Hospital, Shiyan, China. |
| authorships[5].institutions[0].id | https://openalex.org/I4210129556 |
| authorships[5].institutions[0].ror | https://ror.org/02t268r72 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210129556 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | People's Hospital of Shiyan |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Yan Zhang |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Anesthesiology, Yunxi People's Hospital, Shiyan, China. |
| authorships[6].author.id | https://openalex.org/A5040511892 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Haolin Luo |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I180726961 |
| authorships[6].affiliations[0].raw_affiliation_string | Guangdong Provincial Key Laboratory for Plant Epigenetics, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China. |
| authorships[6].institutions[0].id | https://openalex.org/I180726961 |
| authorships[6].institutions[0].ror | https://ror.org/01vy4gh70 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I180726961 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Shenzhen University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Haolin Luo |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Guangdong Provincial Key Laboratory for Plant Epigenetics, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China. |
| authorships[7].author.id | https://openalex.org/A5100647952 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-0812-7132 |
| authorships[7].author.display_name | Hui Yao |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210101555 |
| authorships[7].affiliations[0].raw_affiliation_string | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[7].institutions[0].id | https://openalex.org/I4210101555 |
| authorships[7].institutions[0].ror | https://ror.org/018wg9441 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210101555 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Hubei University of Science and Technology |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Hui Yao |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[8].author.id | https://openalex.org/A5068048707 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7340-0353 |
| authorships[8].author.display_name | Ping Xue |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210101555 |
| authorships[8].affiliations[0].raw_affiliation_string | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[8].institutions[0].id | https://openalex.org/I4210101555 |
| authorships[8].institutions[0].ror | https://ror.org/018wg9441 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210101555 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Hubei University of Science and Technology |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ping Xue |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, China. |
| authorships[9].author.id | https://openalex.org/A5069892877 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Shuai Ni |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I47720641 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Neurosurgery, Union Hospital, Huazhong University of Science and Technology, Wuhan, China. |
| authorships[9].institutions[0].id | https://openalex.org/I47720641 |
| authorships[9].institutions[0].ror | https://ror.org/00p991c53 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I47720641 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Huazhong University of Science and Technology |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Shuai Ni |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Neurosurgery, Union Hospital, Huazhong University of Science and Technology, Wuhan, China. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1603671/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12996 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1305 |
| primary_topic.subfield.display_name | Biotechnology |
| primary_topic.display_name | Cancer Research and Treatments |
| related_works | https://openalex.org/W2106443011, https://openalex.org/W3028962486, https://openalex.org/W2972075105, https://openalex.org/W2108312517, https://openalex.org/W2013077767, https://openalex.org/W2111618277, https://openalex.org/W2154649938, https://openalex.org/W2108398384, https://openalex.org/W4294877544, https://openalex.org/W2139816948 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fmicb.2025.1603671 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2484704948 |
| best_oa_location.source.issn | 1664-302X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1664-302X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Microbiology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1603671/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Microbiology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fmicb.2025.1603671 |
| primary_location.id | doi:10.3389/fmicb.2025.1603671 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2484704948 |
| primary_location.source.issn | 1664-302X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1664-302X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Microbiology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1603671/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Microbiology |
| primary_location.landing_page_url | https://doi.org/10.3389/fmicb.2025.1603671 |
| publication_date | 2025-06-05 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4221040717, https://openalex.org/W2904198922, https://openalex.org/W82937767, https://openalex.org/W4388591162, https://openalex.org/W2473925568, https://openalex.org/W4406326998, https://openalex.org/W3108799736, https://openalex.org/W4393935425, https://openalex.org/W3083277582, https://openalex.org/W6603343749, https://openalex.org/W4403694618, https://openalex.org/W4404486323, https://openalex.org/W2898183660, https://openalex.org/W4298008684, https://openalex.org/W4206832435, https://openalex.org/W4309334544, https://openalex.org/W4401684848, https://openalex.org/W4405466364, https://openalex.org/W2955432103, https://openalex.org/W4384298071, https://openalex.org/W2808801752, https://openalex.org/W4223898939, https://openalex.org/W6775916896, https://openalex.org/W2122328108, https://openalex.org/W2060079355, https://openalex.org/W2975736787, https://openalex.org/W4213030563, https://openalex.org/W3132275965, https://openalex.org/W4405877435, https://openalex.org/W2981672088, https://openalex.org/W3115925815, https://openalex.org/W2062348697, https://openalex.org/W4399362619, https://openalex.org/W4321480081, https://openalex.org/W2884126108, https://openalex.org/W4406140177, https://openalex.org/W2605744811, https://openalex.org/W4283693879, https://openalex.org/W3210896925, https://openalex.org/W3202521679, https://openalex.org/W4405022251, https://openalex.org/W2175610656, https://openalex.org/W3037220005, https://openalex.org/W4360599696, https://openalex.org/W2913218418, https://openalex.org/W4383645699, https://openalex.org/W3030942202, https://openalex.org/W4401356777, https://openalex.org/W4405675998, https://openalex.org/W4402249181, https://openalex.org/W4395958849, https://openalex.org/W4404568440, https://openalex.org/W3201013983, https://openalex.org/W3138215020, https://openalex.org/W2980347658, https://openalex.org/W2965566706, https://openalex.org/W4400101969, https://openalex.org/W2582015180, https://openalex.org/W4281719384, https://openalex.org/W2010815223, https://openalex.org/W4396954829, https://openalex.org/W4390673654, https://openalex.org/W2905439462, https://openalex.org/W4404726556, https://openalex.org/W3015084976, https://openalex.org/W4391754109, https://openalex.org/W2790710405, https://openalex.org/W4401924410, https://openalex.org/W4401004736, https://openalex.org/W4403369658, https://openalex.org/W2800400662, https://openalex.org/W3168109681, https://openalex.org/W2996159114, https://openalex.org/W4406896874, https://openalex.org/W4399868388, https://openalex.org/W4402895422, https://openalex.org/W2946013828 |
| referenced_works_count | 77 |
| abstract_inverted_index., | 36 |
| abstract_inverted_index.By | 59, 136 |
| abstract_inverted_index.E. | 37, 115 |
| abstract_inverted_index.IT | 57, 104 |
| abstract_inverted_index.as | 2, 33, 53 |
| abstract_inverted_index.be | 83 |
| abstract_inverted_index.by | 107 |
| abstract_inverted_index.in | 20 |
| abstract_inverted_index.of | 78 |
| abstract_inverted_index.to | 48, 102, 154 |
| abstract_inverted_index.ITs | 61 |
| abstract_inverted_index.TME | 124 |
| abstract_inverted_index.act | 52 |
| abstract_inverted_index.and | 12, 25, 41, 51, 65, 114, 131, 158 |
| abstract_inverted_index.can | 82 |
| abstract_inverted_index.for | 56, 91, 147, 161 |
| abstract_inverted_index.yet | 150 |
| abstract_inverted_index.RIT, | 141 |
| abstract_inverted_index.This | 95 |
| abstract_inverted_index.coli | 38, 116 |
| abstract_inverted_index.have | 28 |
| abstract_inverted_index.into | 62 |
| abstract_inverted_index.like | 110 |
| abstract_inverted_index.such | 32 |
| abstract_inverted_index.this | 142 |
| abstract_inverted_index.with | 140 |
| abstract_inverted_index.(TME) | 23 |
| abstract_inverted_index.1917, | 40 |
| abstract_inverted_index.hosts | 55 |
| abstract_inverted_index.lysis | 71 |
| abstract_inverted_index.phage | 70 |
| abstract_inverted_index.these | 63 |
| abstract_inverted_index.tumor | 14, 21 |
| abstract_inverted_index.(ITs), | 1 |
| abstract_inverted_index.(RITs) | 81 |
| abstract_inverted_index.(e.g., | 45, 69 |
| abstract_inverted_index.Nissle | 39 |
| abstract_inverted_index.cancer | 4, 148 |
| abstract_inverted_index.demand | 134 |
| abstract_inverted_index.offers | 144 |
| abstract_inverted_index.review | 96 |
| abstract_inverted_index.risks, | 128 |
| abstract_inverted_index.signal | 73 |
| abstract_inverted_index.tumors | 50 |
| abstract_inverted_index.yeast, | 46 |
| abstract_inverted_index.address | 155 |
| abstract_inverted_index.amplify | 103 |
| abstract_inverted_index.dynamic | 123 |
| abstract_inverted_index.enabled | 29 |
| abstract_inverted_index.enhance | 88 |
| abstract_inverted_index.further | 87 |
| abstract_inverted_index.genetic | 26 |
| abstract_inverted_index.peptide | 74 |
| abstract_inverted_index.plasmid | 89 |
| abstract_inverted_index.precise | 67 |
| abstract_inverted_index.safety, | 157 |
| abstract_inverted_index.systems | 86 |
| abstract_inverted_index.Advances | 19 |
| abstract_inverted_index.However, | 119 |
| abstract_inverted_index.approach | 143 |
| abstract_inverted_index.barriers | 160 |
| abstract_inverted_index.circuits | 68 |
| abstract_inverted_index.clinical | 17, 162 |
| abstract_inverted_index.colonize | 49 |
| abstract_inverted_index.confront | 6 |
| abstract_inverted_index.effects, | 10 |
| abstract_inverted_index.microbes | 64, 101 |
| abstract_inverted_index.modified | 42 |
| abstract_inverted_index.persist, | 121 |
| abstract_inverted_index.requires | 151 |
| abstract_inverted_index.systemic | 126 |
| abstract_inverted_index.systems, | 72 |
| abstract_inverted_index.targeted | 3 |
| abstract_inverted_index.therapy, | 149 |
| abstract_inverted_index.achieved. | 84 |
| abstract_inverted_index.adoption. | 163 |
| abstract_inverted_index.delivery. | 94 |
| abstract_inverted_index.efficacy, | 105 |
| abstract_inverted_index.efficient | 54 |
| abstract_inverted_index.employing | 66 |
| abstract_inverted_index.fusions), | 75 |
| abstract_inverted_index.hindering | 16 |
| abstract_inverted_index.including | 8, 122 |
| abstract_inverted_index.infection | 127 |
| abstract_inverted_index.microbial | 138 |
| abstract_inverted_index.platforms | 44 |
| abstract_inverted_index.potential | 146 |
| abstract_inverted_index.secretion | 77 |
| abstract_inverted_index.stability | 90 |
| abstract_inverted_index.successes | 109 |
| abstract_inverted_index.sustained | 92 |
| abstract_inverted_index.targeting | 139 |
| abstract_inverted_index.-delivered | 112 |
| abstract_inverted_index.-expressed | 117 |
| abstract_inverted_index.Salmonella | 35, 111 |
| abstract_inverted_index.TGFα-PE38 | 113 |
| abstract_inverted_index.attenuated | 34 |
| abstract_inverted_index.challenges | 120 |
| abstract_inverted_index.controlled | 76 |
| abstract_inverted_index.engineered | 30, 100 |
| abstract_inverted_index.eukaryotic | 43 |
| abstract_inverted_index.highlights | 97 |
| abstract_inverted_index.inadequate | 13 |
| abstract_inverted_index.innovation | 153 |
| abstract_inverted_index.leveraging | 99 |
| abstract_inverted_index.off-target | 9 |
| abstract_inverted_index.regulatory | 132, 159 |
| abstract_inverted_index.strategies | 98 |
| abstract_inverted_index.technical, | 156 |
| abstract_inverted_index.therapies, | 5 |
| abstract_inverted_index.engineering | 27 |
| abstract_inverted_index.exemplified | 106 |
| abstract_inverted_index.integrating | 60 |
| abstract_inverted_index.limitations | 7 |
| abstract_inverted_index.microalgae) | 47 |
| abstract_inverted_index.preclinical | 108 |
| abstract_inverted_index.production. | 58 |
| abstract_inverted_index.recombinant | 79 |
| abstract_inverted_index.resolution. | 135 |
| abstract_inverted_index.synergizing | 137 |
| abstract_inverted_index.therapeutic | 93 |
| abstract_inverted_index.Immunotoxins | 0 |
| abstract_inverted_index.complexities | 130 |
| abstract_inverted_index.immunotoxins | 80 |
| abstract_inverted_index.penetration, | 15 |
| abstract_inverted_index.translation. | 18 |
| abstract_inverted_index.interactions, | 125 |
| abstract_inverted_index.manufacturing | 129 |
| abstract_inverted_index.uncertainties | 133 |
| abstract_inverted_index.understanding | 24 |
| abstract_inverted_index.microorganisms | 31 |
| abstract_inverted_index.transformative | 145 |
| abstract_inverted_index.Balanced-lethal | 85 |
| abstract_inverted_index.immunogenicity, | 11 |
| abstract_inverted_index.anti-PD-L1-PE38. | 118 |
| abstract_inverted_index.microenvironment | 22 |
| abstract_inverted_index.multidisciplinary | 152 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/9 |
| sustainable_development_goals[0].score | 0.5600000023841858 |
| sustainable_development_goals[0].display_name | Industry, innovation and infrastructure |
| citation_normalized_percentile.value | 0.24765052 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |